LIVE EVENT: The U.S. healthcare law rollout: Where do we stand?
WASHINGTON - The U.S. Supreme Court on Monday left intact a $142 million jury verdict against Pfizer Inc over the company's marketing of the epilepsy drug Neurontin.
TEL AVIV - Teva Pharmaceutical Industries, the world's biggest maker of generic drugs, estimates its pipeline of so-called new therapeutic entities (NTEs) could generate revenue of $1 billion to $1.5 billion by 2018.
- Acura Pharmaceuticals Inc said the U.S. Food and Drug Administration agreed to review the results of a failed mid-stage trial of a painkiller made with the company's technology designed to deter abuse.
NEW YORK - Merck & Co has agreed to settle hundreds of lawsuits over jaw injuries allegedly caused by the osteoporosis drug Fosamax, lawyers disclosed at a court hearing Monday.
NEW YORK (Reuters Health) - Girls who start puberty early may be at particular risk for problem behaviors as teenagers, a new study suggests.
- U.S. Food and Drug Administration staff reviewing data on Boston Scientific Corp's novel anti-stroke device highlighted the implant's failure to meet a key goal for effectiveness in a recent study but said on Monday that other data must be weighed in deciding whether it should be approved.
- An oral immunotherapy aimed at grass and pollen allergies has a benefit and safety profile that supports its approval, according to briefing documents posted on Monday by the U.S. Food and Drug Administration ahead of a meeting by outside experts to discuss the drug.
New York (Reuters Health) - The gold standard for treating childhood obesity currently involves using a family-based approach in which both parents and children attend meetings on losing weight. A new review of past studies suggests parent-only meetings may work just as well.
- United Therapeutics Corp said it received a subpoena from the U.S. Department of Health and Human Services regarding marketing practices used to sell three of its drugs to treat pulmonary arterial hypertension (PAH).
NEW YORK (Reuters Health) - Violent movie characters often engage in other risky behaviors like sex and drinking, according to a new study. Those compounded behaviors also occur equally among PG-13 and R-rated movies.
On Wednesday, December 4 at 10:30 a.m. watch live as experts assess where the U.S. stands in the healthcare law rollout and the resulting health policy implications. Presented by the forum at Harvard School of Public Health in collaboration with Reuters. Live Coverage